When the most relevant patents for OPDIVO expire, we would fully expect biosimilars to enter the market.
Ben Ray Luján: “When the most relevant patents for OPDIVO expire, we would fully expect biosimilars to enter the market.”
Editor's note · Context
Lujan questions commitment to allow biosimilars after OPDIVO patent expiration.
Share
More from Ben Ray Luján
On Indigenous Peoples’ Day, we recognize and honor the accomplishments, contributions, and strength of Tribal Nations across New Mexico and the country.
Under the law, President Trump’s ads might plausibly fall into two categories: the ads are either produced by a ‘legally qualified candidate’ and therefore broadcasters are limited in their ability to censor the ads’ content, or President…
I’ll continue working to lower costs and support small businesses across New Mexico.
Senator Ben Ray Luján helped shape the Fix Our Forests Act through the Senate Agriculture Committee, securing provisions reflecting New Mexico priorities.





